As director of Beth Israel Deaconess’s Center for Virology and Vaccine Research, Barouch is behind a new vaccine that could stop the disease [HIV] in its tracks. [Boston Magazine article]
It takes a cocktail of drugs to treat HIV. It could take a cocktail of antibodies to prevent HIV as well, suggests a study in Science Translational Medicine by Boston-based researchers […]
By Carey Goldberg WBUR At a major international AIDS conference in Paris this week, researchers presented findings on a new HIV vaccine that look promising enough to launch a big clinical […]
By Meera Senthilingham
CNN, July 25th, 2017
A new study found zero transmission of HIV between more than 370 homosexual couples. Preventing new infections while a vaccine is developed is key to controlling the epidemic.
By Julia Belluz
Vox.com July 24th, 2017
The “mosaic vaccine” tackles the virus’s incredible genetic diversity.
National Institutes of Health Press Release
Results from early-stage NIH-funded trial support further development of candidate vaccines.
Beth Israel Deaconess Medical Center Press Release
Mosaic-based vaccine includes characteristics from several common strains of HIV.
In the APPROACH multi-site, randomized and controlled study of 393 healthy people in five countries, investigational vaccines were well-tolerated and elicited antibody responses in 100 percent of volunteers.
Sorry, no posts matched your criteria
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
CVVR Clinical Trials Unit